You are about to undo an edit. Please check the comparison below to verify that this is what you want to do, then publish the changes below to finish undoing the edit. If you are undoing an edit that is not vandalism, explain the reason in the edit summary. Do not use the default message only. |
Latest revision | Your text | ||
Line 28: | Line 28: | ||
==Function== |
==Function== |
||
{{main|Haematopoeisis}} |
{{main|Haematopoeisis}} |
||
Haematopoiesis (from [[Ancient Greek|Greek]] αἷμα, "blood" and ποιεῖν "to make"; also hematopoiesis in |
Haematopoiesis (from [[Ancient Greek|Greek]] αἷμα, "blood" and ποιεῖν "to make"; also hematopoiesis in American English; sometimes also haemopoiesis or hemopoiesis) is the formation of [[blood]] cellular components. All cellular blood components are derived from [[Hematopoietic stem cell|haematopoietic stem cell]]s.<ref name="Birbrair n/a–n/a">{{Cite journal|last1=Birbrair|first1=Alexander|last2=Frenette|first2=Paul S.|date=2016-03-01|title=Niche heterogeneity in the bone marrow|journal=Annals of the New York Academy of Sciences|language=en|pages=82–96|doi=10.1111/nyas.13016|issn=1749-6632|volume=1370|issue=1|pmid=27015419|pmc=4938003|bibcode=2016NYASA1370...82B}}</ref> In a healthy adult person, approximately 10<sup>11</sup>–10<sup>12</sup> new blood cells are produced daily in order to maintain steady state levels in the peripheral circulation.<ref name=T4>Semester 4 medical lectures at Uppsala University 2008 by Leif Jansson</ref><ref>{{cite book |author1=Parslow, T G. |author2=Stites, DP. |author3=Terr, AI. |author4=Imboden JB. |title=Medical Immunology |year=1997 |edition=1 |isbn=978-0-8385-6278-9}}</ref> |
||
All blood cells are divided into three lineages.<ref>{{cite web|title=Hematopoiesis from Pluripotent Stem Cells|publisher=ThermoFisher Scientific|url=http://www.ebioscience.com/resources/pathways/hematopoiesis-from-pluripotent-sem-cells.htm|access-date=3 February 2014}}</ref> |
All blood cells are divided into three lineages.<ref>{{cite web|title=Hematopoiesis from Pluripotent Stem Cells|publisher=ThermoFisher Scientific|url=http://www.ebioscience.com/resources/pathways/hematopoiesis-from-pluripotent-sem-cells.htm|access-date=3 February 2014}}</ref> |
||
Line 39: | Line 39: | ||
===Stem cell transplant=== |
===Stem cell transplant=== |
||
{{main|stem cell transplant}} |
{{main|stem cell transplant}} |
||
A [[stem cell transplant]] is a transplant intended to replace the progenitor [[hematopoietic |
A [[stem cell transplant]] is a transplant intended to replace the progenitor [[hematopoietic stem cell]]s |
||
|
Hematopoietic stem cell transplantation (HSCT) is the transplantation of [[multipotent hematopoietic stem cell]]s, usually derived from bone marrow, peripheral blood, or umbilical cord blood.<ref name="HSCT2">{{cite journal |last1=Felfly |first1=H |last2=Haddad |first2=GG |title=Hematopoietic stem cells: potential new applications for translational medicine |journal=Journal of Stem Cells |date=2014 |volume=9 |issue=3 |pages=163–97 |pmid=25157450}}</ref><ref name="HSCT1">{{cite journal |last1=Park |first1=B |last2=Yoo |first2=KH |last3=Kim |first3=C |title=Hematopoietic stem cell expansion and generation: the ways to make a breakthrough |journal=Blood Research |date=December 2015 |volume=50 |issue=4 |pages=194–203 |pmid=26770947 |doi=10.5045/br.2015.50.4.194 |pmc=4705045}}</ref><ref>{{cite journal |vauthors=Mahla RS| title = Stem cells application in regenerative medicine and disease threpeutics | journal = International Journal of Cell Biology | volume = 2016 | issue = 7 | pages = 1–24 | year = 2016 | pmid = 27516776 | doi = 10.1155/2016/6940283 | pmc = 4969512 | doi-access = free }}</ref> It may be [[autologous stem cell transplantation|autologous]] (the patient's own stem cells are used), [[allotransplantation|allogeneic]] (the stem cells come from a donor) or syngeneic (from an identical twin).<ref name="HSCT2"/><ref name="HSCT1"/> |
||
It is most often performed for patients with certain [[cancer]]s of the [[blood]] or [[bone marrow]], such as [[multiple myeloma]] or [[leukemia]].<ref name="HSCT1"/> In these cases, the recipient's immune system is usually destroyed with radiation or chemotherapy before the transplantation. Infection and [[graft-versus-host disease]] are major complications of [[Allotransplantation|allogeneic]] HSCT.<ref name="HSCT1"/> |
It is most often performed for patients with certain [[cancer]]s of the [[blood]] or [[bone marrow]], such as [[multiple myeloma]] or [[leukemia]].<ref name="HSCT1"/> In these cases, the recipient's immune system is usually destroyed with radiation or chemotherapy before the transplantation. Infection and [[graft-versus-host disease]] are major complications of [[Allotransplantation|allogeneic]] HSCT.<ref name="HSCT1"/> |
||
|
Hematopoietic stem cell transplantation remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases. As survival following the procedure has increased, its use has expanded beyond cancer to [[autoimmune diseases]]<ref>{{cite journal |vauthors=Tyndall A, Fassas A, Passweg J, etal |title=Autologous haematopoietic stem cell transplants for autoimmune disease–feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease |journal=Bone Marrow Transplant |volume=24 |issue=7 |pages=729–34 |year=1999 |pmid=10516675 |doi=10.1038/sj.bmt.1701987|doi-access= }}</ref><ref>{{cite journal |vauthors=Burt RK, Loh Y, Pearce W, etal |title=Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases |journal=JAMA |volume=299 |issue=8 |pages=925–36 |year=2008 |pmid=18314435 |doi=10.1001/jama.299.8.925|doi-access=free }}</ref> and hereditary [[skeletal dysplasia]]s; notably [[malignant infantile osteopetrosis]]<ref name= elsobky2017>{{cite journal |last1=EL-Sobky |first1=Tamer Ahmed |last2=El-Haddad |first2=Alaa |last3=Elsobky |first3=Ezzat |last4=Elsayed |first4=Solaf M. |last5=Sakr |first5=Hossam Moussa |title=Reversal of skeletal radiographic pathology in a case of malignant infantile osteopetrosis following hematopoietic stem cell transplantation |journal=The Egyptian Journal of Radiology and Nuclear Medicine |date=March 2017 |volume=48 |issue=1 |pages=237–43 |doi=10.1016/j.ejrnm.2016.12.013 |doi-access=free | name-list-style=vanc}}</ref><ref name= Hashemi2015>{{cite journal |last1=Hashemi Taheri |first1=Amir Pejman |last2=Radmard |first2=Amir Reza |last3=Kooraki |first3=Soheil |last4=Behfar |first4=Maryam |last5=Pak |first5=Neda |last6=Hamidieh |first6=Amir Ali |last7=Ghavamzadeh |first7=Ardeshir |title=Radiologic resolution of malignant infantile osteopetrosis skeletal changes following hematopoietic stem cell transplantation |journal=Pediatric Blood & Cancer |date=September 2015 |volume=62 |issue=9 |pages=1645–49 |doi=10.1002/pbc.25524 |pmid=25820806 |s2cid=11287381 | name-list-style=vanc}}</ref> and [[mucopolysaccharidosis]].<ref>{{cite journal |last1=Langereis |first1=Eveline J. |last2=den Os |first2=Matthijs M. |last3=Breen |first3=Catherine |last4=Jones |first4=Simon A. |last5=Knaven |first5=Olga C. |last6=Mercer |first6=Jean |last7=Miller |first7=Weston P. |last8=Kelly |first8=Paula M. |last9=Kennedy |first9=Jim |last10=Ketterl |first10=Tyler G. |last11=O'Meara |first11=Anne |last12=Orchard |first12=Paul J. |last13=Lund |first13=Troy C. |last14=van Rijn |first14=Rick R. |last15=Sakkers |first15=Ralph J. |last16=White |first16=Klane K. |last17=Wijburg |first17=Frits A. |title=Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation |journal=The Journal of Bone and Joint Surgery |date=March 2016 |volume=98 |issue=5 |pages=386–95 |doi=10.2106/JBJS.O.00601 |pmid=26935461 | name-list-style=vanc}}</ref> |
||
==References== |
==References== |
Copy and paste: – — ° ′ ″ ≈ ≠ ≤ ≥ ± − × ÷ ← → · § Cite your sources: <ref></ref>
{{}} {{{}}} | [] [[]] [[Category:]] #REDIRECT [[]] <s></s> <sup></sup> <sub></sub> <code></code> <pre></pre> <blockquote></blockquote> <ref></ref> <ref name="" /> {{Reflist}} <references /> <includeonly></includeonly> <noinclude></noinclude> {{DEFAULTSORT:}} <nowiki></nowiki> <!-- --> <span class="plainlinks"></span>
Symbols: ~ | ¡ ¿ † ‡ ↔ ↑ ↓ • ¶ # ∞ ‹› «» ¤ ₳ ฿ ₵ ¢ ₡ ₢ $ ₫ ₯ € ₠ ₣ ƒ ₴ ₭ ₤ ℳ ₥ ₦ № ₧ ₰ £ ៛ ₨ ₪ ৳ ₮ ₩ ¥ ♠ ♣ ♥ ♦ 𝄫 ♭ ♮ ♯ 𝄪 © ® ™
Latin: A a Á á À à  â Ä ä Ǎ ǎ Ă ă Ā ā à ã Å å Ą ą Æ æ Ǣ ǣ B b C c Ć ć Ċ ċ Ĉ ĉ Č č Ç ç D d Ď ď Đ đ Ḍ ḍ Ð ð E e É é È è Ė ė Ê ê Ë ë Ě ě Ĕ ĕ Ē ē Ẽ ẽ Ę ę Ẹ ẹ Ɛ ɛ Ǝ ǝ Ə ə F f G g Ġ ġ Ĝ ĝ Ğ ğ Ģ ģ H h Ĥ ĥ Ħ ħ Ḥ ḥ I i İ ı Í í Ì ì Î î Ï ï Ǐ ǐ Ĭ ĭ Ī ī Ĩ ĩ Į į Ị ị J j Ĵ ĵ K k Ķ ķ L l Ĺ ĺ Ŀ ŀ Ľ ľ Ļ ļ Ł ł Ḷ ḷ Ḹ ḹ M m Ṃ ṃ N n Ń ń Ň ň Ñ ñ Ņ ņ Ṇ ṇ Ŋ ŋ O o Ó ó Ò ò Ô ô Ö ö Ǒ ǒ Ŏ ŏ Ō ō Õ õ Ǫ ǫ Ọ ọ Ő ő Ø ø Œ œ Ɔ ɔ P p Q q R r Ŕ ŕ Ř ř Ŗ ŗ Ṛ ṛ Ṝ ṝ S s Ś ś Ŝ ŝ Š š Ş ş Ș ș Ṣ ṣ ß T t Ť ť Ţ ţ Ț ț Ṭ ṭ Þ þ U u Ú ú Ù ù Û û Ü ü Ǔ ǔ Ŭ ŭ Ū ū Ũ ũ Ů ů Ų ų Ụ ụ Ű ű Ǘ ǘ Ǜ ǜ Ǚ ǚ Ǖ ǖ V v W w Ŵ ŵ X x Y y Ý ý Ŷ ŷ Ÿ ÿ Ỹ ỹ Ȳ ȳ Z z Ź ź Ż ż Ž ž ß Ð ð Þ þ Ŋ ŋ Ə ə
Greek: Ά ά Έ έ Ή ή Ί ί Ό ό Ύ ύ Ώ ώ Α α Β β Γ γ Δ δ Ε ε Ζ ζ Η η Θ θ Ι ι Κ κ Λ λ Μ μ Ν ν Ξ ξ Ο ο Π π Ρ ρ Σ σ ς Τ τ Υ υ Φ φ Χ χ Ψ ψ Ω ω {{Polytonic|}}
Cyrillic: А а Б б В в Г г Ґ ґ Ѓ ѓ Д д Ђ ђ Е е Ё ё Є є Ж ж З з Ѕ ѕ И и І і Ї ї Й й Ј ј К к Ќ ќ Л л Љ љ М м Н н Њ њ О о П п Р р С с Т т Ћ ћ У у Ў ў Ф ф Х х Ц ц Ч ч Џ џ Ш ш Щ щ Ъ ъ Ы ы Ь ь Э э Ю ю Я я ́
IPA: t̪ d̪ ʈ ɖ ɟ ɡ ɢ ʡ ʔ ɸ β θ ð ʃ ʒ ɕ ʑ ʂ ʐ ç ʝ ɣ χ ʁ ħ ʕ ʜ ʢ ɦ ɱ ɳ ɲ ŋ ɴ ʋ ɹ ɻ ɰ ʙ ⱱ ʀ ɾ ɽ ɫ ɬ ɮ ɺ ɭ ʎ ʟ ɥ ʍ ɧ ʼ ɓ ɗ ʄ ɠ ʛ ʘ ǀ ǃ ǂ ǁ ɨ ʉ ɯ ɪ ʏ ʊ ø ɘ ɵ ɤ ə ɚ ɛ œ ɜ ɝ ɞ ʌ ɔ æ ɐ ɶ ɑ ɒ ʰ ʱ ʷ ʲ ˠ ˤ ⁿ ˡ ˈ ˌ ː ˑ ̪ {{IPA|}}
Wikidata entities used in this page
Pages transcluded onto the current version of this page (help):